Epigenetic targets for treatment in acute myeloid leukemia

Published: June 16, 2009
Abstract Views: 139
PDF: 311
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Myelopoiesis, which involves growth and maturation of granulocytic and monocytic lineages, is highly controlled by lineage-specific hematopoietic transcription factors such as AML1, PU-1, C/EBPa, CBFb, retinoic acid receptor a (RARa) etc. that cooperatively interact with specific DNA sequences and directly activate or repress the expression of myeloid specific genes.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Cimino, G., Lo Coco, F., & Nervi, C. (2009). Epigenetic targets for treatment in acute myeloid leukemia. Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.612